for a rise in systemic blood pressure. In addition, neither erythropoietin per se nor the correction of Background. Correction of anaemia in moderate to advanced renal failure is still a matter of debate because haematocrit accelerates the progression of renal damage when blood pressure remains constant. of postulated detrimental effects of erythropoietin on the progression of renal damage.
receiving 100 UI/kg body-wt of rHuEpo i.p. twice a Introduction week ( EPO), and rats receiving rHuEpo in which periodic phlebotomies maintained Htc similar to the In uraemic predialysis patients, treatment with erythrovalue of the control group (PHL). The latter group poietin (rHuEpo) is efficacious in correcting anaemia was included to evaluate the direct effects of rHuEpo and its related symptoms, and therefore in improving on renal damage, i.e. independent from Htc correction.
the quality of life [1] [2] [3] [4] . Importantly, preliminary Results. Two weeks after renal ablation (basal ), Htc evidence suggests that correction of uraemic anaemia decreased in CON and PHL rats (from 49.3±1.4% to diminishes the risk of death for cardiovascular disease; 43.2±1.1, P<0.05 and from 49.6±1.1 to 43.3±1.5%, anaemia, in fact, is a main determinant of cardiac P<0.05 respectively), while it remained consistently hypertrophy in chronic renal failure (CRF ) [5, 6 ] . normal in EPO rats (48.9±1.2% to 48.9±1.5%, Therefore it has been proposed to extend the use of P<0.05 vs other groups). Thereafter Htc did not erythropoietin to CRF of moderate degree and to change throughout the remaining period in all groups.
administer this drug at doses which correct haematocrit At the end of the study, with respect to basal, resting completely [7] [8] [9] . blood pressure increased significantly by the same Such an intriguing new frontier of rHuEpo therapy extent in CON (+13±2%) and EPO rats (+15±5%), is matter of debate because of the controversial data while it remained constant in PHL rats. Notably, suggesting that this approach leads to the progression creatinine clearance significantly decreased in CON of renal damage. Indeed, clinical studies have indicated (−53±8% vs basal ) and EPO (−38±8% vs basal ), that rHuEpo treatment does not worsen, but eventually while it did not change in PHL rats. Likewise the slows, the decline of renal function in predialysis degree of proteinuria as well as renal morphologic patients [2, 3, [10] [11] [12] [13] . Most of these studies, however, alterations and glomerular hypertrophy/sclerosis was are limited not only by a short observation period but similar in CON and EPO rats, and was significantly also by the advanced stage of renal failure in which more severe than in the phlebotomized group. The the effect of rHuEpo was evaluated. Indeed, the glomonly difference detected between CON and EPO group erular and interstitial sclerosis, extensively present in was the greater mesangial hypercellularity in rHuEpoadvanced renal failure [14], does not allow the correct treated rats. assessment of the potential influence of erythropoietin Conclusion. In uraemic rats, chronic treatment with on renal damage. On the contrary, this critical issue rHuEpo aimed at normalization of Htc beginning the should be addressed in renal failure of moderate degree, early stage of renal failure does not inevitably account that is, a condition preceding extensive glomerular sclerosis and obsolescence.
erates the progression of CRF. Specifically, it has been PHL group (n=9) received the drug as in the EPO group;
hypothesized that anaemia has a protective role on Htc was measured weekly, starting from the time of renal residual renal function, while correction of haematocrit artery ligation, and periodic phlebotomies of 0.5-1.5 ml/week enhances renal injury [15, 16 ] . In these sudies, however, were performed from the tail-vein to maintain haematocrit a major hypertensive effect of erythropoietin was levels equal to those of the untreated control rats. All rats observed which possibly influenced the outcome of received iron sulphate supplementation (1 mg/100 g BW/day renal function. In addition, further detrimental effects in tap water 
Subjects and methods
tions (variance coefficient, range 0.5-2%). Systolic blood pressure, creatinine clearance, proteinuria and haematocrit were measured in the normal state (initial Experimental model value), 2 weeks after 5/6 nephrectomy (baseline value of chronic renal failure) and, then, every 2 weeks for 6 more Twenty-seven male Sprague-Dawley rats at an average initial weeks. weight of 301±7 g were anaesthetized (Nembutal 40 mg/kg BW, i.p.), placed on a heated table and the right kidney removed after flank incision (3/6 nephrectomy). Nine of Analytic procedures these kidneys were randomly chosen and used for morphological and morphometric analysis as normal kidneys. After 2 Blood and urine creatinine levels were assessed by the Jaffè weeks, 5/6 nephrectomy was completed by ligating two or method, using an autoanalyser (Creatinine Analyzer 2, three branches of the left renal artery, thus infarcting 2/3 of Beckman, Fullerton, California), and creatinine clearance the residual kidney. Although the infarction model is charac-was calculated by standard formula. Urine protein concentraterized by hypertensive renal injury [21] , it was preferable to tion was measured by phosphoric acid (55%) and methanol the other model of CRF, that is, the surgical excision of (15%) protein assay (Bio-Rad, Munchen, Germany), renal mass, because of the earlier development of the typical detecting the absorbance with a spectronic 301 spectrophotochanges of human CRF such as proteinuria and glomerulo-meter (Milton Roy, New York) at a wavelength of 595 nm. sclerosis [22] .
For haematocrit determinations, NH 4 heparinized microtubes (Brand, Germany) and micro-centrifuge (Bicasa, Sesto S.Giovanni, Italy) at 15 000 r.p.m. were used.
Groups
After subtotal nephrectomy, rats were randomly assigned to Microscopic analysis one of the three experimental groups and studied for 8 weeks. Rats of CON group (n=9) were uraemic untreated controls, After the 8-week-study period, rats were anaesthetized with Nembutal (40 mg/kg BW i.p.) and the remnant kidney was receiving sham-injection. The EPO rats (n=9) received 100 UI/kg BW of rHuEpo i.p. twice a week (Dompé Biotec, excised and processed for histological analysis. Two coronal sections of the kidneys were cut, plastic-embedded and Milan, Italy) from the first day after renal artery ligation. This was the minimal dosage of erythropoietin required to processed by using conventional techniques [24] . Ten serial sections were cut (2 mm thick) with a microtome correct the haematocrit to normal values according to preliminary studies (n=8), in which lower doses of 50 and 75 Reichert-Jung Autocut 2040 (Heidelberg, Germany) with glass knives, and the sections stained with periodic-Schiff (321±14 g in CON, 305±10 g in EPO and 305±10 g stain and haematoxylin-eosin. The glomerular lesions were in PHL) and at the end of the experimental period defined as: (i) glomerulosclerosis: increased extracellular (CON=360±18 g, EPO=338±17 g and PHL= matrix with or without segmental collapse of the glomerular 325±13 g). All animals survived until the end of capillaries evolving to solidification of the tuft and disorgan-the study.
ization of normal architecture (advanced lesions), with possible formation of synechiae between capillary loops and Bowman's capsule; (ii) mesangial expansion: mild increase of Systemic and renal functional data extracellular matrix, without any other glomerular abnormalities and (iii) mesangial hypercellularity: when mesangial areas in one-half or two-thirds of the tuft away from the As depicted in Figure 1 , haematocrit ( Htc) was similar vascular pole [25] contained more mesangial cells than the in the three groups prior to surgery, and it similarly mean +2 standard deviations of those counted in the kidneys decreased in all rats after nephrectomy. At 2 weeks, a from normal rats (our normal value was 5 cells). Thickening mild degree of anaemia was observed in CON and of the glomerular basement membrane was evaluated qualit-PHL (P<0.05 vs initial Htc) groups, while Htc was atively by comparison with glomeruli from normal control restored to normal values in rHuEpo-treated rats kidneys. The tubulointerstitial lesions were examined and (P<0.05 vs CON and PHL) (Figure 1) . Thereafter, graded as previously described [26 ] .
these levels remained steady in all rats.
Microscopic analysis was performed in a blinded fashion Two weeks after nephrectomy creatinine clearance by one observer, evaluating at least 75 different glomeruli in each animal. If a single histological preparation did not was significantly reduced to the same degree in the contain enough glomeruli, a second microscopic section, at three groups (Figure 2 ). Thereafter creatinine clearleast 350 mm away, was examined to avoid the evaluation of ance further decreased in CON and EPO groups, with the same glomerulus. The interval of 350 mm was considered a final variation of −53±8% and −38±8% vs the adequate since the glomerular diameter did not exceed respective 2-week value. At the end of the experimental 300 mm in any glomerulus.
period, it was significantly higher in the PHL group than the CON and EPO groups (P<0.05). No differMorphometry ence in creatinine clearance was detected between EPO and CON during the whole study period.
Three-dimensional quantitative morphometric analysis using Systolic blood pressure (SBP), was significantly Videoplan, Kontron Bildanalyse GMBH-Image Analysis increased in all groups at 2-weeks ( Figure 3 ). Blood System (Zeiss, Germany) was performed on the same sections pressure further increased in both CON and EPO used for morphology.
rats (+13±2% and +15±5% respectively), while it
The cross-sectional capillary tuft areas and the sclerotic remained unchanged in PHL rats. Consequently, at areas were measured with the above-mentioned system by outlining the perimeter of each glomerulus and sclerotic the end of the study, SBP was significantly greater in lesion respectively. The mean values of these parameters both CON and EPO groups compared to PHL were then calculated for each kidney. Since more than 70 (P<0.05).
glomeruli per kidney were evaluated, it was possible to As depicted in Figure 4 , urinary protein excretion calculate the glomerular volume, as previously described was increased in all groups at 2 weeks (P<0.05 vs pre- [27, 28] . Specifically, the following formula was applied: surgery value); thereafter it increased only in CON GV=B/k (GA)3/2, where GV is glomerular volume, B (= and EPO. 1 .38) is the shape coefficient for the sphere, k (=1.1) is the size distribution coefficient and GA is glomerular area. The fractional glomerular sclerotic area was calculated dividing the mean cross-sectional sclerosis area by the mean crosssectional capillary tuft area.
Statistics and calculations
Glomerular morphologic data were analysed by chi-square test. The scores of the tubular and interstitial lesions were analysed by the Kruskal-Wallis (ANOVA multiple comparison) test. For all the other data, the one-way analysis of variance for comparison among different groups was used, and ANOVA for repeated measurements with Bonferroni's correction for multiple comparison analysis in the same group. Results are reported as mean±1 standard error (SE). A P<0.05 was considered statistically significant.
Results

Fig. 1. Haematocrit in untreated remnant rats (CON,--), remnant
Water and food intake was equal in the three groups rats treated with rHuEpo (EPO, .........), and remnant rats treated of rats throughout the study. Body weight was similar with rHuEpo and phlebotomy (PHL, G).°P<0.05 vs PHL; ·P<0.05 vs CON. among the groups, both after subtotal kidney ablation tubular dilatation, interstitial infiltrates were present to the same extent in the three experimental groups.
Morphometry
The glomerular volume in normal kidneys averaged 1.27±0.06×106 mm3. At the end of the study, all experimental groups had developed glomerular hypertrophy; the glomerular volume being considerably greater than in normals (by 212±22% in CON, 188±21% in EPO, and 117±8% in PHL). The degree of hypertrophy in PHL group was significantly lower than in the other groups ( Figure 5 ). The extent of glomerular sclerosis is represented in Figure 5 as the percentage of the total glomerular area. The mean extent of the sclerotic areas was significantly greater in CON and EPO groups (17.7±1.4% and 16.1±1.8% 
Discussion
This study provides evidence that in remnant rats the Histologic data normalization of haematocrit by erythropoietin administration since the very early phase of renal disease Morphology does not worsen either the decline of GFR or the degree of proteinuria and glomerulosclerosis. In normal rats, most glomeruli appeared normal (90%) or with mild aspecific changes; there were no tubuloPrevious work in similar experimental models demonstrated that chronic erythropoietin treatment accelinterstitial lesions detected. At the end of the study all experimental groups exhibited moderate to severe erates the progression of glomerular sclerosis and renal failure [15, 16 ] . However, in these studies, blood histological changes consisting of mesangial enlargement, sclerosis, hypercellularity, thickness and adhe-pressure was further increased by rHuEpo treatment compared to untreated controls. The influence of sion of Bowman's capsule to the tuft (Table 1 ). In particular, mesangial enlargement and sclerosis were erythropoietin-induced hypertension on renal damage may have been critical, since in the remnant rat, prominent in both CON and EPO groups (P<0.001 vs PHL), and greater mesangial hypercellularity systemic arterial pressure greatly accounts for the development of glomerulosclerosis [29] . Therefore, only in the EPO group (P<0.001 vs CON and PHL). Thickness and adhesion of Bowman's capsule were these experimental studies could not adequately explore the direct effects of erythropoietin and correction of present only in CON and EPO rats (P<0.001 vs PHL). Tubulointerstitial lesions, including tubular atrophy, anaemia on the progression of renal damage. Abnormal/normal glomeruli ratio (n/n) and percentage of damaged glomeruli (n) are shown. aP<0.001 vs PHL; bP<0.001 vs CON.
rats employed (Sprague-Dawley in our study and Munich-Wistar in the previous) and/or to a diverse experimental environment. Nevertheless, the absence of a further rise in blood pressure in our rHuEpotreated rats allowed us to investigate the renal effects of the correction of haematocrit by erythropoietin independent from arterial pressure. Interestingly, both the functional and histological studies demonstrated that the progression of renal disease was similar in rats treated with rHuEpo and untreated controls. In fact, no difference was observed between the two groups in the rate of GFR decline, the increment of proteinuria and the extent of glomerulosclerosis. This major finding indicates that the correction of anaemia by rHuEpo within a normal range of haematocrit does not affect the outcome of renal failure when CRF-related hypertension is not further worsened.
More insights into the effects of rHuEpo on the progression of experimental CRF were attained by comparing erythropoietin-treated rats kept anaemic by periodic phlebotomies (PHL) with untreated remnants. This comparison allows one to assess the effect of erythropoietin independent from any changes in haematocrit. PHL rats were characterized by less diffuse and severe glomerular sclerotic lesions and a further decline in renal function did not occur. These findings reasonably rule out the hypothesis of a direct 'nephrotoxic' effect of erythropoietin, previously drawn on the basis of its proliferative activity [17] [18] [19] [20] . In contrast to anaemic untreated control rats and rHuEpo-treated rats, hypertension in the PHL group did not get worse throughout the follow up, possibly explaining the Of note, the blood pressure levels in the rats of this study were consistently higher, regardless the type of treatment, than those attained in other studies [16, 17] . In the current study, in the presence of complete Again, the variance may be ascribed to the rat species correction of haematocrit as in the above-mentioned and/or experimental conditions. One could argue that work [15, 16 ] , the arterial pressure was similar in EPO the major hypertensive state may have masked an and CON rats. The reason for the different blood additional effect of rHuEpo on glomerulosclerosis. pressure response to erythropoietin observed in the This is unlikely since, despite of the presence of high two studies is not readily apparent. Indeed, the discrepblood pressure in all the three groups of animals, it ancy cannot be related to the slight differences in either was possible to observe remarkable differences in the the dose of rHuEpo used or the Htc level reached, but it may be ascribed to the different species of outcome of renal damage. Indeed, PHL rats were 
